[Influence of chemiotherapeutic protocol and neuroendocrine differentiation on metastatic non-small cell lung cancer treatment results].

Author: IlićSrbislav, PetrovićMarina, PlavecGoran, TomićIlija

Paper Details 
Original Abstract of the Article :
In 40-50% of patients with non-small cell lung cancer (NSCLC) at the time of making a diagnosis, the disease is yet at IIIb and IV stage. Standard in the treatment of these patient is the application of systemic chemiotherapy based on CIS/Carboplatin preparations. The aim of this study was to determ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.2298/vsp0709591t

データ提供:米国国立医学図書館(NLM)

Targeting Metastatic Non-Small Cell Lung Cancer: A Multi-faceted Approach

This study delves into the complexities of treating metastatic non-small cell lung cancer (NSCLC), a challenging form of cancer that often presents at advanced stages. The researchers investigated the impact of different chemotherapy protocols and neuroendocrine differentiation on treatment outcomes and survival rates in patients with metastatic NSCLC. The study highlights the need for a personalized approach to treatment, taking into account factors such as the patient's specific characteristics and the biological features of their tumor.

A Desert Oasis of Hope: Seeking Effective Treatment for Lung Cancer

This research underscores the importance of finding the most effective chemotherapy protocols and treatment strategies for patients with metastatic NSCLC. The study's findings emphasize the need for ongoing research to identify new and more effective treatments for this complex and challenging disease. The development of personalized treatment plans that take into account the specific characteristics of the patient and their tumor holds great promise for improving outcomes and survival rates.

Navigating the Complexities of Lung Cancer Treatment

The treatment of lung cancer, like navigating a vast and challenging desert, requires careful planning, a multidisciplinary approach, and an understanding of the unique characteristics of each patient's journey. This study highlights the importance of continued research and innovation to develop more effective and targeted therapies for patients with this devastating disease.

Dr.Camel's Conclusion

This research explores the complex challenges of treating metastatic non-small cell lung cancer, emphasizing the need for a personalized approach that considers both the patient's specific characteristics and the biological features of their tumor. The study highlights the importance of continued research and innovation in the field of oncology, aiming to develop more effective and targeted therapies that can improve outcomes and survival rates for patients with this challenging disease.
Date :
  1. Date Completed 2008-01-10
  2. Date Revised 2019-09-17
Further Info :

Pubmed ID

17969813

DOI: Digital Object Identifier

10.2298/vsp0709591t

Related Literature

SNS
PICO Info
in preparation
Languages

Serbian

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.